Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Matcham George | Director | 6 | $0 | $0 | 2026-06-11 |
| Binder Gwendolyn | Director | 6 | $0 | $0 | 2026-06-11 |
| Gibson Neil W | Director | 6 | $0 | $0 | 2026-06-11 |
| McGaughy R Kent Jr | Director | 12 | $9.00M | $0 | 2026-06-11 |
| Laumas Sandeep | CFO and CBO | 14 | $0 | $701.7K | 2025-09-10 |
| Crouch Bronson | CEO and Chairman | 15 | $9.00M | $0 | 2025-04-25 |
| Nielsen Jack | Director, 10% Owner | 8 | $6.00M | $0 | 2023-06-14 |
| Ray Sumita | Chief Legal and Admin Officer | 2 | $0 | $0 | 2023-01-18 |
| MOORE TIMOTHY L. | Chief Operating Officer | 1 | $0 | $0 | 2022-09-06 |
| Chiruvolu Vijay | Chief Technical Officer | 5 | $0 | $0 | 2022-05-20 |
| Roberts Zachary | Chief Medical Officer | 5 | $0 | $0 | 2022-03-04 |
| Curative Ventures V LLC | 10% Owner | 7 | $9.00M | $0 | 2021-03-23 |
| Vivo Capital Fund IX, L.P. | 10% Owner | 5 | $6.00M | $0 | 2021-03-23 |
| Shah Nimish P | Director | 16 | $6.00M | $0 | 2021-03-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Binder Gwendolyn | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 0 | — | $0 | 6,500 | SEC↗ |
| Matcham George | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Laumas Sandeep | CFO and CBO | M Exercise deriv | 2025-09-10 | 2025-09-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | M Exercise deriv | 2025-09-10 | 2025-09-12 | 13,000 | — | $0 | 30,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | S Sale | 2025-09-10 | 2025-09-12 | 17,539 | $23.04 | $404.1K | 12,461 | SEC↗ |
| Laumas Sandeep | CFO and CBO | S Sale | 2025-09-10 | 2025-09-12 | 12,461 | $23.88 | $297.6K | 0 | SEC↗ |
| Laumas Sandeep | CFO and CBO | M Exercise | 2025-09-10 | 2025-09-12 | 13,000 | $12.68 | $164.8K | 30,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | M Exercise | 2025-09-10 | 2025-09-12 | 17,000 | $11.60 | $197.2K | 17,000 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Matcham George | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Binder Gwendolyn | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2025-04-25 | 2025-04-28 | 105,157 | — | $0 | 105,157 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2025-04-25 | 2025-04-28 | 44,851 | — | $0 | 44,851 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2024-09-18 | 2024-09-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2024-09-18 | 2024-09-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Binder Gwendolyn | Director | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Matcham George | Director | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2024-02-10 | 2024-02-13 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2024-02-10 | 2024-02-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Matcham George | Director | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Binder Gwendolyn | Director | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Ray Sumita | Chief Legal and Admin Office | A Award deriv | 2023-01-18 | 2023-01-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Ray Sumita | Chief Legal and Admin Office | A Award deriv | 2023-01-08 | 2023-01-20 | 415,000 | — | $0 | 415,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2023-01-08 | 2023-01-20 | 415,000 | — | $0 | 415,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2023-01-08 | 2023-01-20 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| MOORE TIMOTHY L. | Chief Operating Officer | A Award deriv | 2022-09-06 | 2022-09-06 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Matcham George | Director | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Binder Gwendolyn | Director | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Chiruvolu Vijay | Chief Technical Officer | A Award deriv | 2022-05-20 | 2022-05-25 | 154,237 | — | $0 | 154,237 | SEC↗ |
| McGaughy R Kent Jr | Director | J Other | 2022-03-15 | 2022-03-17 | 260,323 | — | $0 | 8,218,467 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2022-03-04 | 2023-01-20 | 234,000 | — | $0 | 234,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2022-03-04 | 2023-01-20 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Chiruvolu Vijay | Chief Technical Officer | A Award deriv | 2022-03-04 | 2022-03-07 | 257,000 | $8.62 | $2.22M | 257,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2022-03-04 | 2022-03-07 | 234,000 | $8.62 | $2.02M | 234,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2022-03-04 | 2022-03-07 | 750,000 | $8.62 | $6.46M | 750,000 | SEC↗ |
| Roberts Zachary | Chief Medical Officer | A Award deriv | 2022-03-04 | 2022-03-07 | 245,000 | $8.62 | $2.11M | 245,000 | SEC↗ |
| Roberts Zachary | Chief Medical Officer | A Award deriv | 2021-10-07 | 2021-10-08 | 120,000 | — | $0 | 240,000 | SEC↗ |
| Roberts Zachary | Chief Medical Officer | A Award deriv | 2021-09-10 | 2021-09-13 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2021-05-11 | 2021-05-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2021-05-11 | 2021-05-13 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Roberts Zachary | Chief Medical Officer | A Award deriv | 2021-05-11 | 2021-05-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Chiruvolu Vijay | Chief Technical Officer | A Award deriv | 2021-05-11 | 2021-05-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Chiruvolu Vijay | Chief Technical Officer | A Award deriv | 2021-04-30 | 2021-05-13 | 154,237 | — | $0 | 154,237 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion deriv | 2021-03-23 | 2021-03-25 | 5,082,333 | — | $0 | 0 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion deriv | 2021-03-23 | 2021-03-25 | 25,000,000 | — | $0 | 0 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion deriv | 2021-03-23 | 2021-03-25 | 1,192,729 | — | $0 | 0 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion deriv | 2021-03-23 | 2021-03-25 | 1,192,729 | — | $0 | 0 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion deriv | 2021-03-23 | 2021-03-25 | 5,082,333 | — | $0 | 0 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion deriv | 2021-03-23 | 2021-03-25 | 25,000,000 | — | $0 | 0 | SEC↗ |
| McGaughy R Kent Jr | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 795,152 | — | $0 | 0 | SEC↗ |
| McGaughy R Kent Jr | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 5,895,507 | — | $0 | 0 | SEC↗ |
| Nielsen Jack | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 397,576 | — | $0 | 0 | SEC↗ |
| Nielsen Jack | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 9,758,080 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 425,025 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 358,693 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 4,250,722 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 400,597 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | C Conversion deriv | 2021-03-23 | 2021-03-25 | 35,861 | — | $0 | 0 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion deriv | 2021-03-23 | 2021-03-25 | 9,758,080 | — | $0 | 0 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion deriv | 2021-03-23 | 2021-03-25 | 397,576 | — | $0 | 0 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion | 2021-03-23 | 2021-03-25 | 6,098,799 | — | $0 | 36,098,799 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion | 2021-03-23 | 2021-03-25 | 30,000,000 | — | $0 | 30,000,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | C Conversion | 2021-03-23 | 2021-03-25 | 1,431,274 | — | $0 | 37,530,073 | SEC↗ |
| Crouch Bronson | CEO and Chairman | P Buy | 2021-03-23 | 2021-03-25 | 450,000 | $20.00 | $9.00M | 37,980,073 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion | 2021-03-23 | 2021-03-25 | 1,431,274 | — | $0 | 37,530,073 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion | 2021-03-23 | 2021-03-25 | 6,098,799 | — | $0 | 36,098,799 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | C Conversion | 2021-03-23 | 2021-03-25 | 30,000,000 | — | $0 | 30,000,000 | SEC↗ |
| Curative Ventures V LLC | 10% Owner | P Buy | 2021-03-23 | 2021-03-25 | 450,000 | $20.00 | $9.00M | 37,980,073 | SEC↗ |
| McGaughy R Kent Jr | Director | C Conversion | 2021-03-23 | 2021-03-25 | 954,182 | — | $0 | 8,028,790 | SEC↗ |
| McGaughy R Kent Jr | Director | C Conversion | 2021-03-23 | 2021-03-25 | 7,074,608 | — | $0 | 7,074,608 | SEC↗ |
| McGaughy R Kent Jr | Director | P Buy | 2021-03-23 | 2021-03-25 | 450,000 | $20.00 | $9.00M | 8,478,790 | SEC↗ |
| Nielsen Jack | Director | C Conversion | 2021-03-23 | 2021-03-25 | 11,709,696 | — | $0 | 11,709,696 | SEC↗ |
| Nielsen Jack | Director | P Buy | 2021-03-23 | 2021-03-25 | 300,000 | $20.00 | $6.00M | 12,486,787 | SEC↗ |
| Nielsen Jack | Director | C Conversion | 2021-03-23 | 2021-03-25 | 477,091 | — | $0 | 12,186,787 | SEC↗ |
| Shah Nimish P | Director | P Buy | 2021-03-23 | 2021-03-25 | 48,390 | $20.00 | $967.8K | 48,390 | SEC↗ |
| Shah Nimish P | Director | P Buy | 2021-03-23 | 2021-03-25 | 116,880 | $20.00 | $2.34M | 597,596 | SEC↗ |
| Shah Nimish P | Director | P Buy | 2021-03-23 | 2021-03-25 | 10,470 | $20.00 | $209.4K | 563,533 | SEC↗ |
| Shah Nimish P | Director | P Buy | 2021-03-23 | 2021-03-25 | 19,620 | $20.00 | $392.4K | 19,620 | SEC↗ |
| Shah Nimish P | Director | P Buy | 2021-03-23 | 2021-03-25 | 104,640 | $20.00 | $2.09M | 5,635,937 | SEC↗ |
| Shah Nimish P | Director | C Conversion | 2021-03-23 | 2021-03-25 | 480,716 | — | $0 | 480,716 | SEC↗ |
| Shah Nimish P | Director | C Conversion | 2021-03-23 | 2021-03-25 | 43,033 | — | $0 | 553,063 | SEC↗ |
| Shah Nimish P | Director | C Conversion | 2021-03-23 | 2021-03-25 | 430,431 | — | $0 | 5,531,297 | SEC↗ |
| Shah Nimish P | Director | C Conversion | 2021-03-23 | 2021-03-25 | 510,030 | — | $0 | 510,030 | SEC↗ |
| Shah Nimish P | Director | C Conversion | 2021-03-23 | 2021-03-25 | 5,100,866 | — | $0 | 5,100,866 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | P Buy | 2021-03-23 | 2021-03-25 | 300,000 | $20.00 | $6.00M | 12,486,787 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion | 2021-03-23 | 2021-03-25 | 477,091 | — | $0 | 12,186,787 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion | 2021-03-23 | 2021-03-25 | 11,709,696 | — | $0 | 11,709,696 | SEC↗ |
| Binder Gwendolyn | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Chiruvolu Vijay | Chief Technical Officer | A Award deriv | 2021-03-18 | 2021-03-22 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Crouch Bronson | CEO and Chairman | A Award deriv | 2021-03-18 | 2021-03-22 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Laumas Sandeep | CFO and CBO | A Award deriv | 2021-03-18 | 2021-03-22 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Matcham George | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| McGaughy R Kent Jr | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Nielsen Jack | Director, 10% Owner | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Roberts Zachary | Chief Medical Officer | A Award deriv | 2021-03-18 | 2021-03-22 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Shah Nimish P | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |